“The proposed registration requirements for telemedicine-based prescribing and dispensing create a new business activity within DEA’s overarching registration framework, distinguishing it from ...

One such exception is for providers who hold a “special registration,” the details of which were left within the DEA’s purview. This is the first time the DEA has proposed a special ...

which is an administrative action to determine whether a DEA certificate of registration should be revoked. Representatives for Truepill did not respond to a request for comment. Between September ...

The underlying idea behind the special registration pathway is that clinicians who want to prescribe a controlled substance via telemedicine without an in-person visit would register with the DEA.

As discussed in our prior LawFlash, DEA issued a proposed rule on January 17, 2025 for a special registration process ... applications and perform certificate management activities (e.g., renewals ...

Consequently, Richie’s DEA Certificate of Registration was suspended, and an Immediate Suspension Order was issued. The DEA deemed the company’s continued operation to be an imminent danger to ...

On Wednesday, the DEA released a proposed rule that would set up a special registration process for remote prescribing of Schedule II-V controlled substances such as Xanax, Vicodin and Adderall.

“DEA is open to considering — for some controlled substances — implementation of a separate Special Registration for telemedicine prescribing for patients without requiring the patient to ...

The omission prevents pharmacists from obtaining DEA registration, limiting their ability to prescribe medications, including those for opioid use disorder, according to a March 4 ASHP news release.